Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2191-2200 of 2760 for cancer

Edit search filters
  1. Melanoma In-transit Tissue Bank and Molecular Analysis for Personalized Therapies

    Rochester, MN, Jacksonville, FL

  2. A Study to Evaluate Family Member Exposure to Antineoplastic Drugs in the Home Setting

    Eau Claire, WI

  3. A Study to Evaluate Plasma and Sputum As Noninvasive Biomarkers for Bronchial Dysplasia Progression/Regression

  4. Assessment of the Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Systemic Therapy and Surgery, UTMOST Trial

    Rochester, MN

  5. CT of the Breast: Feasibility and Comparison with MRI in Women with Breast Cancer

  6. A Study to Evaluate Cancer Distress, Psychological Trauma, and Resiliency in Hospitalized Hematopoietic Stem Cell Transplant Patients

    Jacksonville, FL

  7. Preclinical drug testing and assay development for lung adenocarcinoma characterized by the expression of ASCL1

    Rochester, MN

  8. Evaluating Surgical Treatment Related Differences in Patient Satisfaction and Health-related Quality of Life in Breast Cancer Survivors in the Long-term Survivorship Period

    Rochester, MN

  9. Targeting Inflammation for Endometrial Cancer Prevention

    Jacksonville, FL, Scottsdale/Phoenix, AZ

  10. Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer

    Rochester, MN

.

Mayo Clinic Footer